Want to see HUM full AI Analyst Report?

Humana (HUM) Stock Forecast & Price Target

2,724 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

HUM Analyst Ratings

Moderate Buy

11 Buy

10 Hold

2 Sell

Based on 23 analysts giving stock ratings to

Humana

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

HUM Stock 12 Month Forecast

Average Price Target

$420.67

▲(8.05% Upside)

Based on 23 Wall Street analysts offering 12 month price targets for Humana in the last 3 months. The average price target is $420.67 with a high forecast of $624.00 and a low forecast of $249.00. The average price target represents a 8.05% change from the last price of $389.32.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"175":"$175","400":"$400","625":"$625","287.5":"$287.5","512.5":"$512.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":624,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$624.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":420.6666666666667,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$420.67</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":249,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$249.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[175,287.5,400,512.5,625],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,409.42,425.92615384615385,442.4323076923077,458.9384615384615,475.4446153846154,491.9507692307692,508.4569230769231,524.9630769230769,541.4692307692308,557.9753846153847,574.4815384615384,590.9876923076923,607.4938461538461,{"y":624,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,409.42,410.2851282051282,411.1502564102564,412.0153846153846,412.8805128205128,413.745641025641,414.6107692307692,415.4758974358975,416.3410256410257,417.2061538461539,418.0712820512821,418.9364102564103,419.8015384615385,{"y":420.6666666666667,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,409.42,397.08000000000004,384.74,372.40000000000003,360.06,347.72,335.38,323.04,310.7,298.36,286.02,273.68,261.34000000000003,{"y":249,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":248.987,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 33, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":243.742,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":299.34,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":244.109,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":275.19,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":239.617,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":254.235,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":185.815,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 28, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":185.895,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":176.533,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 34, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":233.08,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":327.537,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":409.42,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$624.00

Average Price Target$420.67

Lowest Price Target$249.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Ryan Langston

TD Cowen

$350→$370

Hold

-4.96%

Downside

Assigned

07/31/26

Humana Price Target Raised to $370 as Margin Recovery Prospects Balance Ongoing Execution Risks, Supporting Hold Rating

Andrew Mok CFA

Barclays

$344→$407

Hold

4.54%

Upside

Reiterated

07/31/26

Humana (HUM) Receives a Hold from Barclays

David S Macdonald

Truist Financial

$415

Hold

6.60%

Upside

Reiterated

07/30/26

Analysts' Top Healthcare Picks: Tilray (TLRY), Humana (HUM)

A.J. Rice

UBS

$320→$405

Hold

4.03%

Upside

Reiterated

07/30/26

UBS Remains a Hold on Humana (HUM)

Michael Wiederhorn

Oppenheimer

$340→$405

Buy

4.03%

Upside

Assigned

07/30/26

Humana price target raised to $405 from $340 at OppenheimerHumana price target raised to $405 from $340 at Oppenheimer

George Hill

Deutsche Bank

$441→$436

Buy

11.99%

Upside

Reiterated

07/30/26

Humana price target lowered to $436 from $441 at Deutsche BankHumana price target lowered to $436 from $441 at Deutsche Bank

Scott Fidel

Goldman Sachs

$195→$280

Sell

-28.08%

Downside

Reiterated

07/30/26

Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (NASDAQ: GEHC), Humana (NYSE: HUM) and Ocular Therapeutix (NASDAQ: OCUL)

Whit Mayo

Leerink Partners

$255→$513

Buy

31.77%

Upside

Upgraded

07/30/26

Humana price target raised to $513 from $255 at LeerinkHumana price target raised to $513 from $255 at Leerink

Matthew Gillmor CFA

KeyBanc

―

Hold

―

Reiterated

07/30/26

Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (NASDAQ: ADPT), Humana (NYSE: HUM) and Teladoc (NYSE: TDOC)

Parker Snure

Raymond James

―

Hold

―

Downgraded

07/30/26

Humana downgraded to Market Perform from Outperform at Raymond JamesHumana downgraded to Market Perform from Outperform at Raymond James

Michael Ha

Robert W. Baird

$205→$390

Hold

0.17%

Upside

Reiterated

07/30/26

Humana price target raised to $390 from $205 at BairdHumana price target raised to $390 from $205 at Baird

Jessica Tassan

Piper Sandler

$254→$463

Buy

18.93%

Upside

Upgraded

07/30/26

Humana upgraded to Overweight from Neutral at Piper SandlerHumana upgraded to Overweight from Neutral at Piper Sandler

Erin Wright

Morgan Stanley

$249

Sell

-36.04%

Downside

Reiterated

07/29/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Humana (NYSE: HUM), Boston Scientific (NYSE: BSX) and Acadia Healthcare (NASDAQ: ACHC)

Ben Hendrix

RBC Capital

$415

Hold

6.60%

Upside

Reiterated

07/29/26

RBC Capital Sticks to Its Hold Rating for Humana (HUM)

Stephen Baxter

Wells Fargo

$502

Buy

28.94%

Upside

Assigned

07/29/26

Analysts Are Bullish on Top Healthcare Stocks: MannKind (MNKD), Humana (HUM)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Ryan Langston

TD Cowen

$350→$370

Hold

-4.96%

Downside

Assigned

07/31/26

Humana Price Target Raised to $370 as Margin Recovery Prospects Balance Ongoing Execution Risks, Supporting Hold Rating

Andrew Mok CFA

Barclays

$344→$407

Hold

4.54%

Upside

Reiterated

07/31/26

Humana (HUM) Receives a Hold from Barclays

David S Macdonald

Truist Financial

$415

Hold

6.60%

Upside

Reiterated

07/30/26

Analysts' Top Healthcare Picks: Tilray (TLRY), Humana (HUM)

A.J. Rice

UBS

$320→$405

Hold

4.03%

Upside

Reiterated

07/30/26

UBS Remains a Hold on Humana (HUM)

Michael Wiederhorn

Oppenheimer

$340→$405

Buy

4.03%

Upside

Assigned

07/30/26

Humana price target raised to $405 from $340 at OppenheimerHumana price target raised to $405 from $340 at Oppenheimer

George Hill

Deutsche Bank

$441→$436

Buy

11.99%

Upside

Reiterated

07/30/26

Humana price target lowered to $436 from $441 at Deutsche BankHumana price target lowered to $436 from $441 at Deutsche Bank

Scott Fidel

Goldman Sachs

$195→$280

Sell

-28.08%

Downside

Reiterated

07/30/26

Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (NASDAQ: GEHC), Humana (NYSE: HUM) and Ocular Therapeutix (NASDAQ: OCUL)

Whit Mayo

Leerink Partners

$255→$513

Buy

31.77%

Upside

Upgraded

07/30/26

Humana price target raised to $513 from $255 at LeerinkHumana price target raised to $513 from $255 at Leerink

Matthew Gillmor CFA

KeyBanc

―

Hold

―

Reiterated

07/30/26

Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (NASDAQ: ADPT), Humana (NYSE: HUM) and Teladoc (NYSE: TDOC)

Parker Snure

Raymond James

―

Hold

―

Downgraded

07/30/26

Humana downgraded to Market Perform from Outperform at Raymond JamesHumana downgraded to Market Perform from Outperform at Raymond James

Michael Ha

Robert W. Baird

$205→$390

Hold

0.17%

Upside

Reiterated

07/30/26

Humana price target raised to $390 from $205 at BairdHumana price target raised to $390 from $205 at Baird

Jessica Tassan

Piper Sandler

$254→$463

Buy

18.93%

Upside

Upgraded

07/30/26

Humana upgraded to Overweight from Neutral at Piper SandlerHumana upgraded to Overweight from Neutral at Piper Sandler

Erin Wright

Morgan Stanley

$249

Sell

-36.04%

Downside

Reiterated

07/29/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Humana (NYSE: HUM), Boston Scientific (NYSE: BSX) and Acadia Healthcare (NASDAQ: ACHC)

Ben Hendrix

RBC Capital

$415

Hold

6.60%

Upside

Reiterated

07/29/26

RBC Capital Sticks to Its Hold Rating for Humana (HUM)

Stephen Baxter

Wells Fargo

$502

Buy

28.94%

Upside

Assigned

07/29/26

Analysts Are Bullish on Top Healthcare Stocks: MannKind (MNKD), Humana (HUM)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

MLYSMineralys Therapeutics, Inc.

AMLXAmylyx Pharmaceuticals Inc

ZURAZura Bio

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Humana

3 Months

Michael WiederhornOppenheimer

Success Rate

25/40 ratings generated profit

Average Return

+3.64%

Copying Michael Wiederhorn's trades and holding each position for 3 Months would result in 62.50% of your transactions generating a profit, with an average return of +3.64% per trade.

1 Year

Michael WiederhornOppenheimer

Success Rate

24/40 ratings generated profit

Average Return

+8.58%

Copying Michael Wiederhorn's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +8.58% per trade.

2 Years

Michael WiederhornOppenheimer

Success Rate

31/40 ratings generated profit

Average Return

+18.43%

Copying Michael Wiederhorn's trades and holding each position for 2 Years would result in 77.50% of your transactions generating a profit, with an average return of +18.43% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HUM Analyst Recommendation Trends

Rating

Mar 26

Apr 26

May 26

Jun 26

Jul 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, HUM has received 18 Buy Ratings, 23 Hold Ratings, and 4 Sell Ratings. HUM average Analyst price target in the past 3 months is 420.67.

Each month's total comprises the sum of three months' worth of ratings.

HUM Financial Forecast

HUM Earnings Forecast

Next quarter’s earnings estimate for HUM is -$0.82 with a range of -$1.29 to $0.47. The previous quarter’s EPS was $7.61. HUM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.79% of the time in the same period. In the last calendar year HUM has Performed in-line its overall industry.

HUM Sales Forecast

Next quarter’s sales forecast for HUM is $40.89B with a range of $40.43B to $41.42B. The previous quarter’s sales results were $40.87B. HUM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.18% of the time in the same period. In the last calendar year HUM has Performed in-line its overall industry.

HUM Stock Forecast FAQ

What is HUM’s average 12-month price target, according to analysts?

Based on analyst ratings, Humana Inc’s 12-month average price target is 420.67.

What is HUM’s upside potential, based on the analysts’ average price target?

Humana Inc has 8.05% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is HUM a Buy, Sell or Hold?

Humana Inc has a consensus rating of Moderate Buy which is based on 11 buy ratings, 10 hold ratings and 2 sell ratings.

What is Humana Inc’s price target?

The average price target for Humana Inc is 420.67. This is based on 23 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $624.00 ,the lowest forecast is $249.00. The average price target represents 8.05% Increase from the current price of $389.32.

What do analysts say about Humana Inc?

Humana Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 23 Wall Streets Analysts.

How can I buy shares of HUM?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Humana (HUM) Stock Forecast & Price Target

HUM Analyst Ratings

HUM Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Humana

HUM Analyst Recommendation Trends

HUM Financial Forecast

HUM Earnings Forecast

HUM Sales Forecast

HUM Stock Forecast FAQ

Detailed List of Analyst Forecasts